Enrission India Capital Joins Ottonomy's ₹40.6 Cr Round
Japan-based Enrission India Capital has joined Ottonomy's post-seed round of about ₹40.6 crore ($4.2 million). Ottonomy makes Ottobot, an autonomous delivery robot used in hospitals and industrial sites.
Enrission India Capital, a Japan-based venture firm, has joined the post-seed funding round of Ottonomy, a maker of autonomous delivery robots. The round totals about ₹40.6 crore ($4.2 million), according to Enrission's announcement.
The announcement does not say who led it.
What is and is not disclosed
The announcement came from the investor, not from Ottonomy, and it names no lead investor, no other participants, no valuation and no closing date. We could not find a second report of the round, so the amount rests on that one statement. Ottonomy's founder and CEO, Ritukar Vijay, is quoted welcoming Enrission as a partner and says the backing will help the company expand globally and bring its robot to more customers.
What Ottonomy sells
Ottonomy makes Ottobot, a delivery robot that works both indoors and outdoors and runs on what the company calls Contextual AI, its navigation software. It says the robot lets hospitals and industrial sites automate deliveries with little human involvement. Ottonomy has been around since late 2020, when Vijay and three co-founders started it, and its 2022 funding announcement was datelined Brooklyn, New York. That year it closed a $3.3 million seed round led by pi Ventures, which took its total funding to $4.9 million at the time. YourStory has since put total funding at $8.2 million over six years, though we could not open that report to confirm. In healthcare, Ottobots have been delivering medical items at Hancock Regional Hospital in Indiana since late 2025, in a launch with Arrive AI, according to public reports.
The labour shortage argument
Enrission frames the investment around staff shortages. Its principal, Harsh Deodhar, said labour shortages are reshaping healthcare and industry, and that skilled staff in hospitals spend too much of their day carrying supplies instead of caring for patients. That is the pitch, and the announcement gives no figures for how many hours a robot saves or how many hospitals use one. The company says it serves healthcare and industrial customers and is expanding globally, without naming them.
Unnamed customers make the traction hard to judge.
Who Enrission is
Enrission India Capital describes itself as a Japan-based venture firm that backs early-stage Indian startups from seed to Series B and helps them reach the Japanese market. It lists GoDesi, Pico Xpress, Uravu Labs, StackBox and Hexalog among its portfolio. In my view, the Japan link is the part worth tracking here, because Japan is a market with an ageing workforce and a long record with service robots, and Ottonomy has said nothing yet about plans there.
Robotics money is spread thin
Indian-founded robotics companies are drawing cheques at many stages. We covered Peppermint Robotics' ₹100 crore pre-Series B, which pi Ventures also led, as well as ANSCER Robotics' ₹45 crore Series A and Coratia Technologies' ₹66 crore Indian Navy deal. Ottonomy's round is smaller than most of these, and the open questions are who else is in it and how many paying customers it has.
